Clinical Trials Directory

Trials / Conditions / Refractory or Relapsed Multiple Myeloma

Refractory or Relapsed Multiple Myeloma

5 registered clinical trials studyying Refractory or Relapsed Multiple Myeloma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combina
NCT06952478
CelltrionPhase 3
UnknownLCAR-B4822M-02 Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma
NCT03674463
Second Affiliated Hospital of Xi'an Jiaotong UniversityPhase 1
UnknownClinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple Myeloma
NCT03716856
First Affiliated Hospital of Zhejiang UniversityPhase 1
UnknownClinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma
NCT03380039
Xinhua Hospital, Shanghai Jiao Tong University School of MedicineN/A
UnknownLCAR-B38M Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma
NCT03090659
Nanjing Legend Biotech Co.Phase 1 / Phase 2